InsidersTradesSigma
大洋生物: management transactions · France · AMF
SZSE:003017FR·AMFMcap 2.5Bn€
Browse the full directors' dealings record of 大洋生物, a listed equity based in France. Shares are quoted on FR FR, under the authority of AMF. Market capitalisation: €2.5bn. The latest transaction was filed on 28 February 2024 — Purchase. Among the most active insiders: 叶剑飞. The full history is free.
2
Insider Decl.
0
Thresholds
·
2 ops.
Buy Volume
·
0 ops.
Sell Volume
Financial data
FY ended December 2025 · cache
31.88 €
Income statement
Revenue1.05 Bn€
Gross profit239.4 M€23% margin
Net income99.9 M€9.6% margin
Balance sheet & cash
Market cap2.51 Bn€
Total debt366.9 M€
Free Cash Flow83.7 M€
Last declaration on 28 February 2024